Leading the way in innovation for over 50 years, we build greater futures for businesses across multiple industries and 131 countries.
Our expert, committed team put our shared beliefs into action – every day. Together, we combine innovation and collective knowledge to create the extraordinary.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
eConsent – What does it truly entail?
Dr. Hilde Vanaken
Head Industry Leaders, Lifesciences & Healthcare, TCS ADD Platforms
Diversity, inclusivity, and accessibility are the new buzz words in clinical trials. An equitable access to easily understandable, unbiased, and consistent communication of any study for informed decision making is the first and foremost fundamental step for any clinical trial participant.
Despite criticality of this process, consenting continues to remain a painful, cumbersome, and inefficient process to date. What is eConsenting and how does it ease the burden off the site staff. How does the industry need to look eConsent? What are the key considerations when implementing eConsent?
Learn how we can help you bring drugs to the market faster.
Talk to our expertsFind out more